BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioMidwest

  Cleveland-Cliffs Reports Final Results of the Company-Wide COVID Vaccination Incentive Program

  Cleveland-Cliffs Inc. (NYSE: CLF) today announced the results of its COVID-19 Vaccination Incentive Program.

  August 24, 2021

   · 

  2 min read
• Drug Development

  Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients

  Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK) , today announced that its SARS-CoV-2 (virus that causes COVID-19) neutralizing monoclonal antibody combination therapy, BRII-196/BRII-198 (“combination BRII-196/BRII-198"),

  August 24, 2021

   · 

  7 min read
• Over the Counter & Diet Supplementary Market by Technology, Application, Trends and Growth Forecasts 2021 – 2028

  Over the Counter medicines are safe if they are administered as per the instructions given by healthcare professionals. OTC medicines includes NSAIDs, cough cold products etc.

  August 24, 2021

   · 

  4 min read
• Pharmaceutical Grade Sorbitol Market by Type, Demand and Production Volumes (In Tons & Region) Forecast to 2028

  Pharmaceutical Grade Sorbitol is a form of a sugar alcohol mainly used in drug industry as a sweetener or as a humectant in most of the preparations.

  August 24, 2021

   · 

  4 min read
• Entheon Biomedical Corp. Announces DTC Eligibility

  The DTC is the largest securities depository in the world and facilitates electronic settlement of stock certificate transfers in the United States.

  August 24, 2021

   · 

  4 min read
• Drug Development

  Tarsier Pharma Raises Capital to Execute Phase-3 Clinical Trial

  Tarsier Pharma today announced it raised capital to execute a phase-3 clinical trial of its TRS01 program in the US and Europe .

  August 24, 2021

   · 

  2 min read
• Bio NC

  Cancer Advances, Inc. Announces Publication, “Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model” in Cancer Prevention Research

  Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces a new publication in Cancer Prevention Research, a journal of the American Association for Cancer Research.

  August 24, 2021

   · 

  2 min read
• Business

  Fosun Pharma Announces 2021 Interim Results

  Shanghai Fosun Pharmaceutical (Group) Co., Ltd (“Fosun Pharma” or “the Group"; Stock Code: 600196.SH, 02196.HK), a leading healthcare group in China, announced its interim results for the first half of 2021 (“the Reporting Period”).

  August 24, 2021

   · 

  12 min read
• OSE Immunotherapeutics Announces Upcoming Investor Conferences and R&D Day

  OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that the Company will be present at the following investor events: H.C. Wainwright 23rd Annual Global Investment Conference - September 13 - 15, 2021

  August 24, 2021

   · 

  5 min read
• Smart Meter Announces Launch of iGlucose Blood Glucose Monitoring (BGM) System for Use in Managing Gestational Diabetes

  Company’s cellular-connected blood glucose solution provides remote patient monitoring (RPM) for simplified and improved patient care and support during pregnancy

  August 24, 2021

   · 

  2 min read